Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of trifluridine/tipiracil in combination with bevacizumab in older and younger patients with refractory metastatic colorectal cancer: A subgroup analysis of the phase 3 SUNLIGHT trial.
Authors
Julien Taieb
Université Paris-Cité, (Paris Descartes), Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France
Julien Taieb , Gerald W. Prager , Marwan Fakih , Fortunato Ciardello , Eric Van Cutsem , Elena Elez , Felipe Melo Cruz , Lucjan S. Wyrwicz , Daniil Stroyakovskiy , Zsuzsanna Papai , Pierre-Guillaume Poureau , Gabor Liposits , Chiara Cremolini , Igor Bondarenko , Dominik Paul Modest , Lucas Roby , Valentine Barboux , Nadia Amellal , Josep Tabernero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT04737187
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 111)
DOI
10.1200/JCO.2024.42.3_suppl.111
Abstract #
111
Poster Bd #
G15
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.
First Author: Yoshinori Kagawa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world effectiveness and safety of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: A retrospective observational study using an administrative database.
First Author: Eiji Shinozaki
Poster
2016 Gastrointestinal Cancers Symposium
Efficacy and safety of bevacizumab combined with fluoropyrimidine monotherapy in unfit or older metastatic colorectal cancer patients: A systematic review and pooled-analysis.
First Author: Lorenzo Antonuzzo
Poster
2013 ASCO Annual Meeting
Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer.
First Author: Mark P. Saunders